The post Rising “Buy the Dip” Chatter May Predict Further Decline appeared on BitcoinEthereumNews.com. Key Points: Santiment observes increased “buy the dip” mentions amid Bitcoin’s price decline. Caution urged; not a definite market bottom signal. Historical patterns show crowd optimism often precedes further declines. On August 31st, Santiment, a crypto sentiment analysis platform, reported a surge in social media mentions of “buying the dip” amid Bitcoin’s ongoing price decline. This trend suggests uncertainty among investors, but analysts warn against seeing it as a market bottom signal, often associated with fear and declining interest in buying. Bitcoin’s Market Struggles Amid Cautious Investor Sentiment As of August 31, according to CoinMarketCap, Bitcoin (BTC) stands at $108,803.08, with a market cap of approximately $2.17 trillion. Despite a recovering 24-hour price of 0.57%, the 7-day statistic shows a -5.31% change. The fully diluted market cap is at about $2.28 trillion, while the 24-hour trading volume decreased by 42.58% to approximately $45.64 billion. Coincu’s research team suggests that relying solely on social sentiment as a market predictor poses risks in interpreting Bitcoin’s path. Historical trends reveal that optimism during decline can indicate more potential for price falls, underscoring the volatility and unpredictability in crypto markets. For those keeping an eye on Bitcoin’s journey, some are hopeful about its potential as certain predictions point toward a likely Bitcoin potential rise to 150K in the longer term. “Don’t interpret ‘buy the dip’ chatter as a definitive bottom signal. A true market floor often coincides with widespread fear and a lack of interest in buying.” – Santiment official report Market Data and Trends Did you know? Historically, spikes in social media mentions of “buy the dip” often signify potential market declines rather than recoveries, highlighting the complexity of using crowd sentiment as a market indicator. As of August 31, Bitcoin’s trading volume and market cap reflect ongoing volatility in the crypto market,… The post Rising “Buy the Dip” Chatter May Predict Further Decline appeared on BitcoinEthereumNews.com. Key Points: Santiment observes increased “buy the dip” mentions amid Bitcoin’s price decline. Caution urged; not a definite market bottom signal. Historical patterns show crowd optimism often precedes further declines. On August 31st, Santiment, a crypto sentiment analysis platform, reported a surge in social media mentions of “buying the dip” amid Bitcoin’s ongoing price decline. This trend suggests uncertainty among investors, but analysts warn against seeing it as a market bottom signal, often associated with fear and declining interest in buying. Bitcoin’s Market Struggles Amid Cautious Investor Sentiment As of August 31, according to CoinMarketCap, Bitcoin (BTC) stands at $108,803.08, with a market cap of approximately $2.17 trillion. Despite a recovering 24-hour price of 0.57%, the 7-day statistic shows a -5.31% change. The fully diluted market cap is at about $2.28 trillion, while the 24-hour trading volume decreased by 42.58% to approximately $45.64 billion. Coincu’s research team suggests that relying solely on social sentiment as a market predictor poses risks in interpreting Bitcoin’s path. Historical trends reveal that optimism during decline can indicate more potential for price falls, underscoring the volatility and unpredictability in crypto markets. For those keeping an eye on Bitcoin’s journey, some are hopeful about its potential as certain predictions point toward a likely Bitcoin potential rise to 150K in the longer term. “Don’t interpret ‘buy the dip’ chatter as a definitive bottom signal. A true market floor often coincides with widespread fear and a lack of interest in buying.” – Santiment official report Market Data and Trends Did you know? Historically, spikes in social media mentions of “buy the dip” often signify potential market declines rather than recoveries, highlighting the complexity of using crowd sentiment as a market indicator. As of August 31, Bitcoin’s trading volume and market cap reflect ongoing volatility in the crypto market,…

Rising “Buy the Dip” Chatter May Predict Further Decline

Key Points:
  • Santiment observes increased “buy the dip” mentions amid Bitcoin’s price decline.
  • Caution urged; not a definite market bottom signal.
  • Historical patterns show crowd optimism often precedes further declines.

On August 31st, Santiment, a crypto sentiment analysis platform, reported a surge in social media mentions of “buying the dip” amid Bitcoin’s ongoing price decline.

This trend suggests uncertainty among investors, but analysts warn against seeing it as a market bottom signal, often associated with fear and declining interest in buying.

Bitcoin’s Market Struggles Amid Cautious Investor Sentiment

As of August 31, according to CoinMarketCap, Bitcoin (BTC) stands at $108,803.08, with a market cap of approximately $2.17 trillion. Despite a recovering 24-hour price of 0.57%, the 7-day statistic shows a -5.31% change. The fully diluted market cap is at about $2.28 trillion, while the 24-hour trading volume decreased by 42.58% to approximately $45.64 billion.

Coincu’s research team suggests that relying solely on social sentiment as a market predictor poses risks in interpreting Bitcoin’s path. Historical trends reveal that optimism during decline can indicate more potential for price falls, underscoring the volatility and unpredictability in crypto markets. For those keeping an eye on Bitcoin’s journey, some are hopeful about its potential as certain predictions point toward a likely Bitcoin potential rise to 150K in the longer term.

Did you know? Historically, spikes in social media mentions of “buy the dip” often signify potential market declines rather than recoveries, highlighting the complexity of using crowd sentiment as a market indicator.

As of August 31, Bitcoin’s trading volume and market cap reflect ongoing volatility in the crypto market, with significant fluctuations noted in recent days.

Bitcoin(BTC), daily chart, screenshot on CoinMarketCap at 07:08 UTC on August 31, 2025. Source: CoinMarketCap

Analysts continue to warn that while social media sentiment may indicate optimism, it is crucial to approach such indicators with caution, as they often precede further declines rather than recoveries.

Source: https://coincu.com/markets/santiment-buy-dip-warning/

Market Opportunity
Threshold Logo
Threshold Price(T)
$0.009904
$0.009904$0.009904
-0.16%
USD
Threshold (T) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26